Mainz Biomed B.V.(MYNZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MYNZ Mainz Biomed B.V.

Not Yet Opened 11-14 16:00:00 EST

0.2500

+0.0000

0.00%

盘后0.2500

+0.00000.00%

19:59 EST

High0.2600	Low0.2240	Vol4.79M
Open0.2570	D1 Closing0.2500	Amplitude14.40%
Mkt Cap6.40M	Tradable Cap5.52M	Total Shares25.59M
T/O1.16M	T/O Rate21.70%	Tradable Shares22.09M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"MYNZ","market":"US","secType":"STK","nameCN":"Mainz Biomed B.V.","latestPrice":0.25,"timestamp":1731618000000,"preClose":0.25,"halted":0,"volume":4793918,"hourTrading":{"tag":"盘后","latestPrice":0.25,"preClose":0.25,"latestTime":"19:59 EST","volume":59136,"amount":14404.3784,"timestamp":1731632360647},"delay":0,"floatShares":22089200,"shares":25586600,"eps":-1.124457,"marketStatus":"Not Yet Opened","change":0,"latestTime":"11-14 16:00:00 EST","open":0.257,"high":0.26,"low":0.224,"amount":1162127.6991978,"amplitude":0.144,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.124457,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1731661200000},"marketStatusCode":0,"adr":0,"listingDate":1635998400000,"exchange":"NASDAQ","adjPreClose":0.25,"preHourTrading":{"tag":"盘前","latestPrice":0.26,"preClose":0.25,"latestTime":"09:23 EST","volume":150536,"amount":39481.216718480006,"timestamp":1731594217604},"postHourTrading":{"tag":"盘后","latestPrice":0.25,"preClose":0.25,"latestTime":"19:59 EST","volume":59136,"amount":14404.3784,"timestamp":1731632360647},"volumeRatio":0.368276},"requestUrl":"/m/hq/s/MYNZ/tweets","defaultTab":"tweets","newsList":[{"id":"2483629278","title":"The Oncology Bet Is Already Paying Off For Pfizer","url":"https://stock-news.laohu8.com/highlight/detail?id=2483629278","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483629278?lang=en_us&edition=fundamental","pubTime":"2024-11-14 08:23","pubTimestamp":1731543795,"startTime":"0","endTime":"0","summary":"With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc  reported its third quarter revenue grew14% on an operational basisdue to approved cancer products from Seagen it acquired last December. On the other hand, Moderna Inc  posted a surprise profit and higher than expected revenue following the launch of its updated Covid-19 vaccine earlier this year as focused on slashing costs. But, even with Covid-19 still lingering in the air, Moderna has also focused on harnessing the power of mRNA to make biotech history by revolutionizing cancer treatment. However, there is also a significant advancement in early screening and even possible prevention when it comes to the cancer front. For example, their much smaller peer,Mainz Biomed  just announced a new collaboration agreement aimed at developing and potentially commercializing its next generation colorectal cancer screening product.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/T17My1Xowf0ctud5YtvJcg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/eeac3cc78e2352f7fe351184c2b1bf99","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/T17My1Xowf0ctud5YtvJcg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/eeac3cc78e2352f7fe351184c2b1bf99"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/oncology-bet-already-paying-off-002315025.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0342679015.USD","LU1923622291.USD","LU1023059063.AUD","BK4581","LU0868494617.USD","BK4568","LU0225284248.USD","BK4535","LU1791710400.SGD","BK4550","LU0557290698.USD","LU1791710582.SGD","LU2089984988.USD","MYNZ","LU0528227936.USD","TMO","LU0061474960.USD","GRO","LU2092937221.SGD","LU0122379950.USD","BK4551","IE000M9KFDE8.USD","IE0034235188.USD","LU0114720955.EUR","LU0170899867.USD","BK4534","LU1280957306.USD","SG9999011175.SGD","IE00BLSP4452.SGD","LU1883839398.USD","LU1623119135.USD","SG9999001176.USD","BK4139","BK4533","LU1291159041.SGD","BK4566","LU0321505868.SGD","LU1720051108.HKD","LU1894683348.USD","MRNA","IE00BJJMRZ35.SGD","PFE","IE0002141913.USD","BK4585","GB00BDT5M118.USD","LU1712237335.SGD","IE0002270589.USD","LU1923622614.USD","IE00B19Z3B42.SGD"],"gpt_icon":1},{"id":"2482082994","title":"Mainz Biomed Partners with Thermo Fisher for Cancer Screening","url":"https://stock-news.laohu8.com/highlight/detail?id=2482082994","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482082994?lang=en_us&edition=fundamental","pubTime":"2024-11-12 23:39","pubTimestamp":1731425964,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed has announced a collaboration with Thermo Fisher Scientific to develop a next-generat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-partners-with-thermo-fisher-for-cancer-screening?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-partners-with-thermo-fisher-for-cancer-screening?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2482008676","title":"Mainz Biomed, Thermo Fisher Partner to Develop Colorectal Cancer Screening Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2482008676","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482008676?lang=en_us&edition=fundamental","pubTime":"2024-11-12 22:54","pubTimestamp":1731423296,"startTime":"0","endTime":"0","summary":"Mainz Biomed N.V  said Tuesday it has partnered with Thermo Fisher Scientific  to develop a colorectal cancer screening test.Financial details of the partnership were not disclosed.Mainz said the partnership will combine its experience in mRNA-based colorectal cancer detection with Thermo Fisher's technology resources to develop a non-invasive test for detecting early-stage colorectal cancer and precancerous growths.Shares of Mainz Biomed rose nearly 7% in recent Tuesday trading, while Thermo Fisher's rose 0.3%.Price: 0.23, Change: +0.01, Percent Change: +6.51","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0882574055.USD","BK4548","BK4139","BK4581","GB00BDT5M118.USD","LU1791710400.SGD","LU1670628061.USD","TMO","LU0528227936.USD","LU0342679015.USD","LU1854103824.USD","LU0823416689.USD","LU1923621640.USD","LU1280957306.USD","IE00BJJMRZ35.SGD","LU1023059063.AUD","LU1548497426.USD","LU0557290698.USD","LU1988902786.USD","LU2041044095.USD","LU2092937221.SGD","LU1633808545.USD","LU1854104046.USD","LU0266013472.USD","BK4534","IE00B19Z8W00.USD","LU1815333072.USD","LU1057294990.SGD","LU0640476718.USD","LU0957791311.USD","LU2089984988.USD","LU1791710582.SGD","LU0011850046.USD","IE00B2B36J28.USD","IE00BJT1NW94.SGD","IE00B1BXHZ80.USD","LU1720051017.SGD","LU0061474960.USD","LU1720051108.HKD","LU0316494557.USD","LU1064131342.USD","LU1670627923.USD","MYNZ","LU0096362180.USD","BK4566","IE0002141913.USD","LU1923622291.USD","LU1989771016.USD","BK4535","BK4533"],"gpt_icon":0},{"id":"2482088244","title":"Mainz Biomed, Thermo Fisher sign collaboration agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2482088244","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482088244?lang=en_us&edition=fundamental","pubTime":"2024-11-12 22:15","pubTimestamp":1731420942,"startTime":"0","endTime":"0","summary":"Mainz Biomed (MYNZ) announced a collaborative agreement with Thermo Fisher Scientific (TMO), through its subsidiary Life Technologies. The collabor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mainz-biomed-thermo-fisher-sign-collaboration-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mainz-biomed-thermo-fisher-sign-collaboration-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B19Z9505.USD","IE00BJJMRZ35.SGD","LU0266013472.USD","LU0342679015.USD","LU0316494557.USD","LU1923622614.USD","LU1720051017.SGD","LU1983299246.USD","LU0823416689.USD","LU1064131342.USD","TMO","LU1633808545.USD","IE00BFTCPJ56.SGD","GB00BDT5M118.USD","LU0061474960.USD","LU1791710400.SGD","LU1291159041.SGD","LU1854104046.USD","LU0011850046.USD","IE00B19Z8W00.USD","LU1988902786.USD","LU1023059063.AUD","MYNZ","LU1989771016.USD","LU0957791311.USD","LU0234572021.USD","LU0114720955.EUR","IE00B1BXHZ80.USD","IE0002141913.USD","LU0096362180.USD","LU1057294990.SGD","LU1923621640.USD","LU2063271972.USD","LU2089984988.USD","BK4588","IE00BJT1NW94.SGD","IE00B19Z8X17.USD","BK4533","LU0882574055.USD","LU0122379950.USD","IE00BKPKM429.USD","BK4585","LU1791710582.SGD","BK4535","LU1670627923.USD","LU1623119135.USD","LU2041044095.USD","BK4139","BK4566","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"2482002327","title":"Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2482002327","media":"GlobeNewswire","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2482002327?lang=en_us&edition=fundamental","pubTime":"2024-11-12 22:00","pubTimestamp":1731420000,"startTime":"0","endTime":"0","summary":"BERKELEY, Calif. and MAINZ, Germany, Nov.  12, 2024  (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/11/12/2979299/0/en/Mainz-Biomed-and-Thermo-Fisher-Scientific-Sign-a-Collaboration-Agreement-for-the-Development-of-Next-Generation-Colorectal-Cancer-Screening-Product-for-Global-Markets.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1670627923.USD","LU1983299246.USD","LU0823416689.USD","LU0011850046.USD","IE0009355771.USD","IE00BJJMRZ35.SGD","LU0640476718.USD","IE00B2B36J28.USD","LU1280957306.USD","LU0266013472.USD","LU0096362180.USD","LU1854103824.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0882574055.USD","LU1064131342.USD","LU1670628061.USD","TMO","LU1548497426.USD","IE00B19Z8W00.USD","LU1988902786.USD","LU1712237335.SGD","LU0957791311.USD","LU0316494557.USD","IE00BJT1NW94.SGD","LU1623119135.USD","LU2063271972.USD","LU0234572021.USD","LU2041044095.USD","LU1291159041.SGD","IE0034235188.USD","BK4548","LU1923622291.USD","IE00B19Z9505.USD","IE00B1BXHZ80.USD","LU1720051017.SGD","LU1854104046.USD","BK4581","MYNZ","LU1633808545.USD","LU1815333072.USD","LU1989771016.USD","GRO","IE00BKPKM429.USD","LU0122379950.USD","IE00B19Z8X17.USD","LU1057294990.SGD","LU0061474960.USD","LU1923621640.USD","BK4121"],"gpt_icon":0},{"id":"2481884294","title":"Mainz Biomed NV  expected to post a loss of 25 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2481884294","media":"reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481884294?lang=en_us&edition=fundamental","pubTime":"2024-11-08 23:42","pubTimestamp":1731080539,"startTime":"0","endTime":"0","summary":"Mainz Biomed NV  expected to post a loss of25cents a share - Earnings Preview Mainz Biomed NV MYNZ.OQ, MYNZ.O is expected to show a fall in quarterly revenue when it reports  results on November 11 (e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241108:nL8N3MF20M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ"],"gpt_icon":0},{"id":"2477854512","title":"Mainz Biomed restructured operations, implemented cost reductions","url":"https://stock-news.laohu8.com/highlight/detail?id=2477854512","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477854512?lang=en_us&edition=fundamental","pubTime":"2024-10-21 20:10","pubTimestamp":1729512653,"startTime":"0","endTime":"0","summary":"In September 2024, Mainz Biomed (MYNZ) announced feedback received from the FDA for the breakthrough device designation with the request to expand ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mainz-biomed-restructured-operations-implemented-cost-reductions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mainz-biomed-restructured-operations-implemented-cost-reductions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","MYNZ"],"gpt_icon":0},{"id":"2477854368","title":"Mainz Biomed Reported Revenue Of $0.52M For H1 2024, Up By 4% YoY, EPS Loss Of $(0.49)","url":"https://stock-news.laohu8.com/highlight/detail?id=2477854368","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477854368?lang=en_us&edition=fundamental","pubTime":"2024-10-21 20:06","pubTimestamp":1729512364,"startTime":"0","endTime":"0","summary":"Mainz Biomed Reported Revenue Of $0.52M For H1 2024, Up By 4% YoY, EPS Loss Of $(0.49)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/10/41425566/mainz-biomed-reported-revenue-of-0-52m-for-h1-2024-up-by-4-yoy-eps-loss-of-0-49","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Mainz Biomed Reported Revenue Of $0.52M For H1 2024, Up By 4% YoY, EPS Loss Of $(0.49)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ"],"gpt_icon":0},{"id":"2477851233","title":"Mainz Biomed Reports Mid-Year 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2477851233","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2477851233?lang=en_us&edition=fundamental","pubTime":"2024-10-21 20:01","pubTimestamp":1729512060,"startTime":"0","endTime":"0","summary":"Revenue increases 4% year over year while loss from operations decreases by 32% Pooled Results of ColoFuture and eAArly DETECT studies published at ASCO showing groundbreaking performance with sensiti","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/21/2966168/0/en/Mainz-Biomed-Reports-Mid-Year-2024-Financial-Results-and-Provides-Corporate-Update.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0266512127.USD","LU0456854461.SGD","BK4139","MYNZ","CRC","BK4213"],"gpt_icon":1},{"id":"2476821445","title":"Mainz Biomed Sees Revenue Growth Amid Cost Reductions","url":"https://stock-news.laohu8.com/highlight/detail?id=2476821445","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476821445?lang=en_us&edition=fundamental","pubTime":"2024-10-19 04:28","pubTimestamp":1729283298,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed B.V. reported a 4% rise in revenue to $520,773 for the first half of 2024, driven by ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-sees-revenue-growth-amid-cost-reductions?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-sees-revenue-growth-amid-cost-reductions?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MYNZ"],"gpt_icon":0},{"id":"2474429788","title":"Mainz Biomed Secures Additional $1.5M Funding","url":"https://stock-news.laohu8.com/highlight/detail?id=2474429788","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2474429788?lang=en_us&edition=fundamental","pubTime":"2024-10-10 05:37","pubTimestamp":1728509833,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed B.V. has entered into a supplemental agreement with YA II PN, LTD. for a fourth Pre-P...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-secures-additional-1-5m-funding?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-secures-additional-1-5m-funding?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2473429096","title":"Mainz Biomed reports increased demand for enhanced ColoAlert product","url":"https://stock-news.laohu8.com/highlight/detail?id=2473429096","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473429096?lang=en_us&edition=fundamental","pubTime":"2024-10-08 20:21","pubTimestamp":1728390116,"startTime":"0","endTime":"0","summary":"Mainz Biomed announced increasing demand from existing and prospective laboratory partners for its enhanced ColoAlert product that has been launche...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mainz-biomed-reports-increased-demand-for-enhanced-coloalert-product?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mainz-biomed-reports-increased-demand-for-enhanced-coloalert-product?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2473942644","title":"Mainz Biomed Reports Increased Demand for Enhanced ColoAlert, Existing Partners to Transition to New Version","url":"https://stock-news.laohu8.com/highlight/detail?id=2473942644","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2473942644?lang=en_us&edition=fundamental","pubTime":"2024-10-08 20:01","pubTimestamp":1728388860,"startTime":"0","endTime":"0","summary":"GANZIMMUN Diagnostics to Feature ColoAlert at the 57th Medizinische Woche Baden-BadenBERKELEY, Calif. and MAINZ, Germany, Oct.  08, 2024  (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Bi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/10/08/2959666/0/en/Mainz-Biomed-Reports-Increased-Demand-for-Enhanced-ColoAlert-Existing-Partners-to-Transition-to-New-Version.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","BK4139","BK4213","CRC"],"gpt_icon":0},{"id":"2472622123","title":"Mainz Biomed Executes Convertible Note Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2472622123","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472622123?lang=en_us&edition=fundamental","pubTime":"2024-10-04 05:27","pubTimestamp":1727990835,"startTime":"0","endTime":"0","summary":"Mainz Biomed B.V. (MYNZ) has released an update. Mainz Biomed N.V. has entered into a financial agreement with YA II PN, Ltd. involving a convertib...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-executes-convertible-note-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/mainz-biomed-executes-convertible-note-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2472467588","title":"The Covid Era Tech Promises To Reinvent Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2472467588","media":"Benzinga","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472467588?lang=en_us&edition=fundamental","pubTime":"2024-10-02 02:11","pubTimestamp":1727806297,"startTime":"0","endTime":"0","summary":"Pfizer Inc  made a promiseto outdo cancer, joining its Covid vaccine-peer, Moderna Inc  in turning to oncology for its next growth story. Both Moderna and Pfizer made history during the COVID-19 pandemic thanks to mRNA technology. Now, Moderna and Pfizer embarked on a journey to treat cancer with mRNA science. By using mRNA-based next-generation CRC screening tests, a much smaller and less known pharma player,Mainz Biomed N.V. , is already redefining standards in early cancer detection with its flagship colorectal cancer test ColoAlert, while also tackling cancer prevention.Mainz Biomed Is Gearing Up To Revolutionize Early Cancer Detection. Despite its efforts to translate scientific research into effective medicines for cancer patients, Pfizer is still not near a breakthrough in oncology. Undoubtably, Pfizer is betting big on oncology to turn its ship around, which it showed with the$43 billion acquisition of the cancer drugmaker Seagen. With the combined pipeline,Pfizer is hoping to ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/AnJXoU8hX9pKqgBRkUcOdg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/8d26299d6380dd313cc1391c1f24ad1d","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/AnJXoU8hX9pKqgBRkUcOdg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/8d26299d6380dd313cc1391c1f24ad1d"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/covid-era-tech-promises-reinvent-181137919.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4532","LU1057294990.SGD","LU1894683264.USD","IE00BJT1NW94.SGD","LU0208291251.USD","LU0203347892.USD","BK4534","SGXZ57979304.SGD","BK4548","IE00B19Z3B42.SGD","BK4559","IE00BBT3K403.USD","LU1585245621.USD","LU0265550359.USD","LU0225771236.USD","LU0122379950.USD","LU0058720904.USD","IE0002141913.USD","LU0321505868.SGD","LU0006306889.USD","BK4551","LU1894683348.USD","MRNA","LU0289739699.SGD","LU1066051225.USD","BK4550","IE000M9KFDE8.USD","MYNZ","SG9999001176.USD","IE00BLSP4239.USD","LU0868494617.USD","LU1066051498.USD","LU0211331839.USD","IE0002270589.USD","BK4516","BK4533","LU1093756325.SGD","LU1061106388.HKD","MRK","SG9999001176.SGD","PFE","IE00B1BXHZ80.USD","SG9999011175.SGD","LU0965509283.SGD","LU1066051811.HKD","LU1093756168.USD","BK4007","LU1934455863.HKD","IE00BJJMRZ35.SGD","LU1023059063.AUD"],"gpt_icon":1},{"id":"2472327322","title":"Mainz Biomed CEO issues statement on upcoming milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2472327322","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472327322?lang=en_us&edition=fundamental","pubTime":"2024-10-01 20:17","pubTimestamp":1727785025,"startTime":"0","endTime":"0","summary":"Mainz Biomed released a statement to shareholders highlighting its strategic plans for maximizing shareholder value, clinical developments, and its...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/mainz-biomed-ceo-issues-statement-on-upcoming-milestones?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/mainz-biomed-ceo-issues-statement-on-upcoming-milestones?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2472332481","title":"Mainz Biomed Publishes CEO Statement; CEO Guido Baechler Eyes Major Growth and U.S. FDA Trials in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2472332481","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2472332481?lang=en_us&edition=fundamental","pubTime":"2024-10-01 20:01","pubTimestamp":1727784060,"startTime":"0","endTime":"0","summary":"BERKELEY, Calif. and MAINZ, Germany, Oct. 01, 2024  -- Mainz Biomed N.V.  , a molecular genetics diagnostic company specializing in the early detection of cancer, today released a statement to shareholders highlighting its strategic plans for maximizing shareholder value, clinical developments, and its upcoming FDA trial anticipated for 2025, which aims to pave the way for entry into the U.S. market. Management believes 2025 will be a transformative year, positioning Mainz Biomed for substantial growth in global markets, particularly through its innovative diagnostic solutions.Mainz Biomed, alongside other companies, emphasizes the use of stool-based samples for CRC and advanced adenoma detection due to their direct connection to cancer cells and adenomas. Recent reports suggesting the ease of bloo","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/4gdf1aP2KF31Of5j_v4jzA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/fa079afc58b5fef8ae5aa677600f9292","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/4gdf1aP2KF31Of5j_v4jzA--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/fa079afc58b5fef8ae5aa677600f9292"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/mainz-biomed-publishes-ceo-statement-120100771.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MYNZ","BK4139","BDD"],"gpt_icon":0},{"id":"2468824627","title":"Pfizer Advances On Its Cancer Journey","url":"https://stock-news.laohu8.com/highlight/detail?id=2468824627","media":"Benzinga","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468824627?lang=en_us&edition=fundamental","pubTime":"2024-09-20 22:48","pubTimestamp":1726843708,"startTime":"0","endTime":"0","summary":"On Saturday, Pfizer Inc  presented positive trial data for experimental drug designed for patients suffering fromcancer cachexia during the European Society for Medical Oncology 2024 Congress. Affecting as many as9 million people across the globe, cancer cachexia is a life-threatening condition that causes cancer patients to lose appetite and consequently, weight.Paving The Way For The World’s First Treatment For Cancer Cachexia. Together with Merck & Co Inc , Moderna is currently testing their combined treatment for advanced melanoma in a large-scale Phase III trial. Approximately, 1,089 patients at more than 165 sites across the globe will be tested to assess the efficiency of the experimental vaccine mRNA-4157 that Moderna and Merck co-developed, along with the","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/xy59hsvXNVGBNP1GgEXylg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/64c6e4417ca97e3334ac1ae8f02c232f","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/xy59hsvXNVGBNP1GgEXylg--~B/aD02NzU7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Benzinga/64c6e4417ca97e3334ac1ae8f02c232f"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-advances-cancer-journey-144828266.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1917777945.USD","LU0203345920.USD","LU1061106388.HKD","BK4551","SG9999002224.SGD","LU1116320901.HKD","LU0985320562.USD","IE0002141913.USD","LU0170899867.USD","BK4585","LU0070302665.USD","LU0306806265.USD","LU0985481810.HKD","LU1941712264.USD","LU0211331839.USD","LU1934455863.HKD","SG9999011175.SGD","MYNZ","LU1894683348.USD","LU0306807586.USD","IE00B4R5TH58.HKD","BK4559","BK4550","IE00BFTCPJ56.SGD","LU1430594728.SGD","LU1883839398.USD","BK4534","LU0320765489.SGD","BK4007","LU0265550946.USD","LU1066051225.USD","LU1894683264.USD","BK4568","SG9999003800.SGD","LU0456855351.SGD","LU1093756325.SGD","LU0225284248.USD","MRK","BK4516","LU0861579265.USD","LU1066053197.SGD","IE00B2B36J28.USD","MRNA","LU1116320737.USD","SG9999002232.USD","LU0965508806.USD","IE00B19Z3581.USD","IE0009355771.USD","BK4533","PFE"],"gpt_icon":1},{"id":"2468934588","title":"Mainz Biomed Announces Petra Smeltzer Starke to Join Company as Brand Ambassador","url":"https://stock-news.laohu8.com/highlight/detail?id=2468934588","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2468934588?lang=en_us&edition=fundamental","pubTime":"2024-09-18 20:01","pubTimestamp":1726660860,"startTime":"0","endTime":"0","summary":"Strategic Alliance with Former White House Senior Adviser to Focus on Awareness of Mainz Biomed’s Products and the Importance of Early DetectionBERKELEY, Calif. and MAINZ, Germany, Sept.  18, 2024  (G","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/09/18/2948170/0/en/Mainz-Biomed-Announces-Petra-Smeltzer-Starke-to-Join-Company-as-Brand-Ambassador.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MYNZ","BK4139"],"gpt_icon":0},{"id":"2464326297","title":"Mainz Biomed Expands AI Collaboration With Liquid Biosciences to Include Pancreatic Cancer Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2464326297","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2464326297?lang=en_us&edition=fundamental","pubTime":"2024-09-04 17:32","pubTimestamp":1725442335,"startTime":"0","endTime":"0","summary":"Mainz Biomed  said Wednesday that it expanded its collaboration with Liquid Biosciences to include PancAlert, Mainz Biomed's detection test for pancreatic cancer.The company said the expanded collaboration will allow it to leverage Liquid Biosciences' proprietary artificial intelligence analysis technology platform EMERGE to \"expand and optimize\" novel biomarkers selection for PancAlert.Mainz Biomed said the collaboration's first phase evaluated biomarkers from its research program and based on the results, the partners determined that a PancAlert diagnostic test could be combined with Mainz Biomed's colorectal cancer screening product in the future.The partners plan to continue with the second phase of the collaboration, which covers the evaluation of microbiome biomarkers that were analyzed in collaboration with Microba Life Sciences in 2023, according to the statement. This analysis is expected to be completed in Q4, said Mainz Biomed.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYNZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://mainzbiomed.com","stockEarnings":[{"period":"1week","weight":0.1364},{"period":"1month","weight":-0.1289},{"period":"3month","weight":-0.2537},{"period":"6month","weight":-0.6323},{"period":"1year","weight":-0.7934},{"period":"ytd","weight":-0.7845}],"compareEarnings":[{"period":"1week","weight":-0.0038},{"period":"1month","weight":0.0234},{"period":"3month","weight":0.0704},{"period":"6month","weight":0.1207},{"period":"1year","weight":0.3195},{"period":"ytd","weight":0.2483}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Mainz Biomed N.V. develops and sells in-vitro diagnostic tests for the early detection of cancer in the United States. The company offers ColoAlert, a colorectal cancer diagnostic molecular genetic stool test. It also develops PancAlert, a stool-based screening test for the detection of pancreatic cancer. The company was founded in 2008 and is based in Mainz, Germany.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":0.092926},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.035908},{"month":3,"riseRate":0.666667,"avgChangeRate":0.025772},{"month":4,"riseRate":0,"avgChangeRate":-0.221085},{"month":5,"riseRate":0.333333,"avgChangeRate":0.100258},{"month":6,"riseRate":0,"avgChangeRate":-0.2895},{"month":7,"riseRate":0.666667,"avgChangeRate":0.026169},{"month":8,"riseRate":0,"avgChangeRate":-0.198742},{"month":9,"riseRate":0,"avgChangeRate":-0.185486},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.099325},{"month":11,"riseRate":0.666667,"avgChangeRate":-0.058978},{"month":12,"riseRate":0.666667,"avgChangeRate":-0.035443}],"exchange":"NASDAQ","name":"Mainz Biomed B.V.","nameEN":"Mainz Biomed B.V."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Mainz Biomed B.V.(MYNZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Mainz Biomed B.V.(MYNZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Mainz Biomed B.V.,MYNZ,Mainz Biomed B.V.股票,Mainz Biomed B.V.股票老虎,Mainz Biomed B.V.股票老虎国际,Mainz Biomed B.V.行情,Mainz Biomed B.V.股票行情,Mainz Biomed B.V.股价,Mainz Biomed B.V.股市,Mainz Biomed B.V.股票价格,Mainz Biomed B.V.股票交易,Mainz Biomed B.V.股票购买,Mainz Biomed B.V.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Mainz Biomed B.V.(MYNZ),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Mainz Biomed B.V.(MYNZ) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction